BIOCRYST PHARMACEUTICALS INC (BCRX)

US09058V1035 - Common Stock

7.85  +0.3 (+3.97%)

After market: 7.87 +0.02 (+0.25%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
157.2M
783.15%		270.8M
72.26%		331.412M
22.38%		410.62M
23.90%
EBITDA
YoY % growth
-176.92M
-1.65%		-146.96M
16.93%		-100.506M
31.61%		-37.138M
63.05%
EBIT
YoY % growth
-177.7M
-1.66%		-148.4M
16.49%		-102.161M
31.16%		-35.042M
65.70%
Operating Margin
-113.04%-54.80%-30.83%-8.53%
EPS
YoY % growth
-1.03
4.63%		-1.33
-29.13%		-0.99
25.56%		-0.61
38.20%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.18
25.97%
Revenue
Q2Q % growth		100.29M
21.58%
EBITDA
Q2Q % growth		-12.679M
36.26%
EBIT
Q2Q % growth		-10.543M
49.07%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 -0.17
39.29%		-0.220.0520.98%
Q4 2023
Q2Q % growth		 -0.28
26.32%		-0.25-0.03-12.50%
Q3 2023
Q2Q % growth		 -0.19
17.39%		-0.240.0520.19%
Q2 2023
Q2Q % growth		 -0.24
25.00%		-0.23-0.01-3.06%
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 92.761M
34.87%		87.317M5.444M6.23%
Q4 2023
Q2Q % growth		 93.401M
17.41%		91.807M1.594M1.74%
Q3 2023
Q2Q % growth		 86.742M
14.39%		87.673M-931K-1.06%
Q2 2023
Q2Q % growth		 82.491M
25.88%		82.606M-115K-0.14%
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-2.1% -7.88% 0% 1.91%
Revenue-0.15% -0.04% 0% 1.74%